Dalane W Kitzman Selected Research

neladenoson bialanate

1/2019	Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
11/2018	Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dalane W Kitzman Research Topics

Disease

100	Heart Failure 05/2024 - 09/2002
18	Hypertension (High Blood Pressure) 05/2024 - 01/2002
17	Obesity 05/2024 - 06/2002
14	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 08/2009
13	Type 2 Diabetes Mellitus (MODY) 01/2024 - 09/2015
12	Cardiomyopathies (Cardiomyopathy) 05/2024 - 01/2012
11	Body Weight (Weight, Body) 05/2024 - 02/2003
11	Inflammation (Inflammations) 11/2023 - 11/2012
9	Weight Loss (Weight Reduction) 05/2024 - 09/2011
7	Frailty 11/2023 - 01/2016
7	Chronic Renal Insufficiency 11/2022 - 04/2011
7	Albuminuria 12/2021 - 09/2015
5	Atrial Fibrillation 05/2024 - 07/2009
5	Atherosclerosis 12/2022 - 01/2015
5	Diabetic Nephropathies (Diabetic Nephropathy) 11/2022 - 09/2015
5	Fibrosis (Cirrhosis) 01/2018 - 01/2008
4	Left Ventricular Dysfunction 07/2016 - 03/2005
4	Diastolic Heart Failure 07/2009 - 04/2005
3	Coronary Disease (Coronary Heart Disease) 01/2023 - 05/2002
3	Diabetes Mellitus 12/2022 - 10/2007
3	Overweight 10/2022 - 09/2011
3	Renal Insufficiency (Renal Failure) 01/2022 - 11/2019
3	Chronic Kidney Failure (Chronic Renal Failure) 11/2019 - 05/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018 - 01/2012
3	Ischemia 01/2012 - 08/2006
2	Morbid Obesity 11/2023 - 01/2023
2	Hypotension (Low Blood Pressure) 01/2021 - 06/2016
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 06/2016
2	Syncope (Fainting) 01/2021 - 06/2016
2	Dysbiosis 01/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 12/2018 - 11/2014
2	Weight Gain 01/2018 - 09/2015
2	Neoplasms (Cancer) 01/2018 - 01/2018
2	Chronic Disease (Chronic Diseases) 01/2017 - 11/2012
1	Herpes Zoster 10/2023
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2023

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 11/2023 - 07/2009
10	CreatinineIBA 11/2022 - 07/2009
10	AtrasentanIBA 11/2022 - 09/2015
10	Oxygen (Dioxygen)IBA 01/2022 - 09/2008
9	semaglutideIBA 05/2024 - 01/2023
9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 07/2012
9	pro-brain natriuretic peptide (1-76)IBA 01/2024 - 07/2009
7	DiureticsIBA 05/2024 - 08/2006
7	C-Reactive ProteinIBA 04/2024 - 07/2009
7	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 04/2005
6	SodiumIBA 04/2024 - 01/2002
6	Natriuretic PeptidesIBA 12/2023 - 01/2012
5	dapagliflozinIBA 12/2023 - 11/2021
5	Endothelin Receptor AntagonistsIBA 11/2022 - 11/2019
5	AlbuminsIBA 11/2022 - 09/2015
5	Hemoglobins (Hemoglobin)IBA 01/2019 - 10/2012
5	Spironolactone (Aldactone)FDA LinkGeneric 11/2017 - 03/2009
4	Dobutamine FDA LinkGeneric 11/2018 - 08/2009
4	Mineralocorticoid Receptor AntagonistsIBA 01/2018 - 03/2009
3	Troponin T (Troponin T1)IBA 01/2023 - 07/2017
3	Prealbumin (Transthyretin)IBA 01/2021 - 04/2006
3	CalciumIBA 01/2019 - 11/2009
3	AldosteroneIBA 01/2018 - 01/2008
3	NitratesIBA 09/2017 - 01/2016
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2013 - 08/2006
3	Angiotensin Receptor AntagonistsIBA 05/2013 - 09/2002
3	Antihypertensive Agents (Antihypertensives)IBA 01/2012 - 05/2002
2	Glucagon-Like Peptide-1 ReceptorIBA 04/2024 - 01/2023
2	Sodium-Glucose Transport ProteinsIBA 12/2023 - 01/2023
2	Interleukin-6 (Interleukin 6)IBA 10/2022 - 11/2012
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 01/2018
2	Valine (L-Valine)FDA Link 01/2021 - 01/2015
2	ElectrolytesIBA 01/2021 - 06/2016
2	Isoleucine (L-Isoleucine)FDA Link 01/2021 - 01/2015
2	Endothelin A ReceptorIBA 11/2019 - 05/2016
2	neladenoson bialanateIBA 01/2019 - 11/2018
2	AnthracyclinesIBA 01/2018 - 11/2014
2	Neprilysin (Neutral Endopeptidase)IBA 01/2018 - 07/2016
2	patiromerIBA 01/2018 - 04/2011
2	Cystatin CIBA 07/2017 - 07/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2016 - 01/2016
2	Adrenergic Agents (Adrenergic Drugs)IBA 02/2016 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2015
2	Galectin 3 (LGALS3)IBA 06/2014 - 01/2012
2	Irbesartan FDA LinkGeneric 09/2012 - 05/2011
2	CollagenIBA 11/2011 - 07/2009
2	FenfluramineIBA 04/2005 - 06/2002
1	Furosemide (Lasix)FDA LinkGeneric 05/2024
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 05/2024
1	SymportersIBA 04/2024
1	high fluorescent intermediate IIIBA 11/2023
1	Messenger RNA (mRNA)IBA 10/2023
1	Ethanolamine (Colamine)IBA 10/2023

Therapy/Procedure

34	Therapeutics 05/2024 - 04/2005
8	Caloric Restriction 01/2023 - 01/2016
6	Cardiac Rehabilitation 01/2023 - 12/2013
4	Secondary Prevention 01/2019 - 11/2013
3	Resistance Training 05/2024 - 01/2023
3	Patient Readmission 01/2021 - 06/2016
3	Drug Therapy (Chemotherapy) 12/2018 - 11/2014
2	Home Nursing (Nursing, Home) 05/2016 - 01/2016
2	Contraindications 05/2013 - 02/2013
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 07/2023
1	Traction 01/2023